NYSE:MED - Medifast Stock Price, Price Target & More

$99.78 +1.79 (+1.83 %)

(As of 04/25/2018 08:36 AM ET)

Previous Close$97.99

Today's Range$98.42 - $100.15

52-Week Range$40.00 - $103.87

Volume122,800 shs

Average Volume151,932 shs

Market Capitalization$1.17 billion

P/E Ratio42.79

Dividend Yield1.96%

Beta0.28

About Medifast (NYSE:MED)

Medifast, Inc., through its subsidiaries, produces, distributes, and sells weight loss, weight management, healthy living products, and other consumable health and nutritional products. The company offers bars, bites, pretzels, puffs, oatmeal and cereal crunch products, drinks, hearty choices, pancakes, puddings, soft serves, shakes, smoothies, soft bakes, and soups under the Medifast, OPTAVIA, Thrive by Medifast, Optimal Health by OPTAVIA, Flavors of Home, and Essential 1 brands. It also provides meal replacements comprising vitamins and minerals; and hydration products, as well as other nutrients for health purposes. As of December 31, 2017, Medifast, Inc. operated 16 franchised Medifast weight control centers in Arizona, California, Louisiana, Minnesota, and Wisconsin; and 18 reseller locations in California, Maryland, and Pennsylvania. The company sells its products through various channels, including the Internet, call centers, independent health advisors, medical professionals, franchise weight loss clinics, and direct consumer marketing. Medifast, Inc. was founded in 1980 and is headquartered in Baltimore, Maryland.

Receive MED News and Ratings via Email

Sign-up to receive the latest news and ratings for MED and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Miscellaneous food preparations & kindred products

Sub-IndustryPersonal Products

SectorConsumer Staples

SymbolNYSE:MED

CUSIP58470H10

Webwww.medifast1.com

Phone410-581-8042

Debt

Debt-to-Equity RatioN/A

Current Ratio3.37%

Quick Ratio2.85%

Price-To-Earnings

Trailing P/E Ratio42.79

Forward P/E Ratio30.70

P/E Growth2.01

Sales & Book Value

Annual Sales$301.56 million

Price / Sales3.95

Cash Flow$2.7840 per share

Price / Cash35.84

Book Value$9.10 per share

Price / Book10.96

Profitability

EPS (Most Recent Fiscal Year)$2.29

Net Income$27.72 million

Net Margins9.19%

Return on Equity26.39%

Return on Assets20.81%

Miscellaneous

Employees399

Outstanding Shares11,930,000

How to Become a New Pot Stock Millionaire

Medifast (NYSE:MED) Frequently Asked Questions

What is Medifast's stock symbol?

Medifast trades on the New York Stock Exchange (NYSE) under the ticker symbol "MED."

How often does Medifast pay dividends? What is the dividend yield for Medifast?

Medifast announced a quarterly dividend on Friday, March 16th. Shareholders of record on Friday, March 30th will be paid a dividend of $0.48 per share on Tuesday, May 8th. This represents a $1.92 annualized dividend and a dividend yield of 1.92%. The ex-dividend date of this dividend is Wednesday, March 28th. View Medifast's Dividend History.

How were Medifast's earnings last quarter?

Medifast (NYSE:MED) released its quarterly earnings data on Tuesday, March, 6th. The specialty retailer reported $0.60 earnings per share (EPS) for the quarter, beating the Zacks' consensus estimate of $0.48 by $0.12. The specialty retailer earned $78.01 million during the quarter, compared to the consensus estimate of $73.48 million. Medifast had a return on equity of 26.39% and a net margin of 9.19%. The company's quarterly revenue was up 24.9% on a year-over-year basis. During the same period last year, the business earned $0.34 earnings per share. View Medifast's Earnings History.

When is Medifast's next earnings date?

Medifast is scheduled to release their next quarterly earnings announcement on Thursday, May, 3rd 2018. View Earnings Estimates for Medifast.

What guidance has Medifast issued on next quarter's earnings?

Medifast updated its FY18 earnings guidance on Tuesday, March, 6th. The company provided earnings per share (EPS) guidance of $3.15-3.25 for the period, compared to the Thomson Reuters consensus EPS estimate of $2.56. The company issued revenue guidance of $350-360 million, compared to the consensus revenue estimate of $330.80 million.Medifast also updated its Q1 guidance to $0.84-0.87 EPS.

What price target have analysts set for MED?

2 Wall Street analysts have issued 12 month price objectives for Medifast's stock. Their predictions range from $55.00 to $108.00. On average, they expect Medifast's stock price to reach $81.50 in the next twelve months. View Analyst Ratings for Medifast.

Who are some of Medifast's key competitors?

Some companies that are related to Medifast include McCormick & Company, Incorporated (MKC), Want Want China (WWNTY), Greencore (GNCGY), Farmer Brothers (FARM), China Marine Food Group (CMFO) and Jammin Java (JAMN).

Who are Medifast's key executives?

Medifast's management team includes the folowing people:

Mr. Daniel R. Chard, CEO & Director (Age 53)
Mr. Timothy G. Robinson CPA, Chief Financial Officer (Age 55)
Ms. Jeanne M. City, Exec. VP of HR (Age 58)
Dr. Linda M. Arterburn Ph.D., VP of Scientific & Clinical Affairs
Mr. Jason L. Groves Esq., Exec. VP, Gen. Counsel and Corp. Sec. (Age 47)

Has Medifast been receiving favorable news coverage?

News coverage about MED stock has been trending somewhat positive recently, according to Accern Sentiment Analysis. Accern identifies negative and positive press coverage by monitoring more than 20 million news and blog sources. Accern ranks coverage of companies on a scale of negative one to one, with scores nearest to one being the most favorable. Medifast earned a media sentiment score of 0.15 on Accern's scale. They also gave press coverage about the specialty retailer an impact score of 46.50 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the stock's share price in the next several days.

How do I buy shares of Medifast?

Shares of MED can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Medifast's stock price today?

One share of MED stock can currently be purchased for approximately $99.78.

How big of a company is Medifast?

Medifast has a market capitalization of $1.17 billion and generates $301.56 million in revenue each year. The specialty retailer earns $27.72 million in net income (profit) each year or $2.29 on an earnings per share basis. Medifast employs 399 workers across the globe.

How can I contact Medifast?

Medifast's mailing address is 100 International Drive, Baltimore MD, 21201. The specialty retailer can be reached via phone at 410-581-8042 or via email at [email protected]

MarketBeat Community Rating for Medifast (MED)

Community Ranking:		2.3 out of 5 ( )
Outperform Votes:		171 (Vote Outperform)
Underperform Votes:		196 (Vote Underperform)
Total Votes:		367

MarketBeat's community ratings are surveys of what our community members think about Medifast and other stocks. Vote "Outperform" if you believe MED will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MED will underperform the S&P 500 over the long term. You may vote once every thirty days.

Medifast (NYSE:MED) Price Target and Consensus Rating

(How are Consensus Ratings Calculated?)

2 Wall Street analysts have issued ratings and price targets for Medifast in the last 12 months. Their average twelve-month price target is $81.50, suggesting that the stock has a possible downside of 18.32%. The high price target for MED is $108.00 and the low price target for MED is $55.00. There are currently 1 hold rating and 1 buy rating for the stock, resulting in a consensus rating of "Buy."

	Today	30 Days Ago	90 Days Ago	180 Days Ago
Consensus Rating:	Buy	Buy	Buy	Buy
Consensus Rating Score:	2.50	3.00	2.50	2.50
Ratings Breakdown:	0 Sell Rating(s) 1 Hold Rating(s) 1 Buy Rating(s) 0 Strong Buy Rating(s)	0 Sell Rating(s) 0 Hold Rating(s) 2 Buy Rating(s) 0 Strong Buy Rating(s)	0 Sell Rating(s) 1 Hold Rating(s) 1 Buy Rating(s) 0 Strong Buy Rating(s)	0 Sell Rating(s) 1 Hold Rating(s) 1 Buy Rating(s) 0 Strong Buy Rating(s)
Consensus Price Target:	$81.50	$81.50	$72.00	$64.50
Price Target Upside:	18.32% downside	7.76% downside	0.84% upside	12.13% upside

Medifast (NYSE:MED) Consensus Price Target History

Price Target History for Medifast (NYSE:MED)

Medifast (NYSE:MED) Analyst Ratings History

Show:

Date	Brokerage	Action	Rating	Price Target	Impact on Share Price
4/19/2018	Sidoti	Reiterated Rating	Buy -> Neutral		Medium
3/8/2018	DA Davidson	Boost Price Target	Buy	$108.00	High
8/4/2016	Wunderlich	Boost Price Target	Hold	$32.00 -> $36.00	N/A

(Data available from 4/25/2016 forward)

Medifast (NYSE:MED) Earnings History and Estimates Chart

Earnings by Quarter for Medifast (NYSE:MED)

Medifast (NYSE:MED) Earnings Estimates

2018 EPS Consensus Estimate: $3.25

Quarter	Number of Estimates	Low Estimate	High Estimate	Average Estimate
Q1 2018	1	$0.86	$0.86	$0.86
Q2 2018	1	$0.92	$0.92	$0.92
Q3 2018	1	$0.77	$0.77	$0.77
Q4 2018	1	$0.70	$0.70	$0.70

Medifast (NYSE MED) Earnings History by Quarter

Date	Quarter	Consensus Estimate	Actual EPS	Revenue Estimate	Actual Revenue	Release Link	Conference Call
5/3/2018		$0.86					N/A
3/6/2018	Q4 2017	$0.48	$0.60	$73.48 million	$78.01 million	View	Listen
11/7/2017	Q3 2017	$0.51	$0.55	$74.94 million	$77.20 million	View	N/A
8/8/2017	Q2 2017	$0.53	$0.63	$71.96 million	$75.70 million	View	Listen
5/4/2017	Q1 2017	$0.49	$0.51	$72.36 million	$70.62 million	View	Listen
3/9/2017	Q4 2016	$0.33	$0.34	$65.01 million	$62.50 million	View	Listen
11/3/2016	Q316	$0.45	$0.51	$66.79 million	$68.57 million	View	N/A
8/3/2016	Q216	$0.51	$0.63	$72.01 million	$71.14 million	View	N/A
5/4/2016	Q116	$0.33	$0.42	$69.31 million	$72.30 million	View	N/A
3/10/2016	Q415	$0.35	$0.33	$62.98 million	$61.30 million	View	Listen
11/5/2015	Q315	$0.42	$0.45	$67.00 million	$65.90 million	View	N/A
8/5/2015	Q215	$0.48	$0.48	$72.79 million	$72.20 million	View	N/A
5/7/2015	Q115	$0.35	$0.46	$71.80 million	$73.30 million	View	N/A
3/12/2015	Q414	$0.46	$0.38	$69.40 million	$62.30 million	View	N/A
11/5/2014	Q314	$0.36	$0.47	$76.10 million	$74.00 million	View	N/A
8/7/2014	Q114	$0.40	$0.44	$87.30 million	$80.88 million	View	N/A
5/5/2014	Q1	$0.37	$0.45	$87.60 million	$86.50 million	View	N/A
3/10/2014	Q413	$0.36	$0.39	$80.83 million	$77.30 million	View	N/A
11/5/2013	Q313	$0.42	$0.41	$95.07 million	$86.48 million	View	N/A
8/6/2013	Q2 2013	$0.51	$0.51	$101.30 million	$97.10 million	View	N/A
5/8/2013	Q1 2013	$0.34	$0.43	$93.77 million	$96.00 million	View	N/A
3/7/2013	Q4 2012	$0.25	$0.28	$82.90 million	$83.20 million	View	N/A
11/5/2012	Q312	$0.40	$0.42	$89.73 million	$91.00 million	View	N/A
7/26/2012		$0.38	$0.47			View	N/A
5/8/2012		$0.38	$0.29			View	N/A
3/13/2012		$0.21	$0.08			View	N/A
11/3/2011		$0.38	$0.36			View	N/A
8/4/2011		$0.47	$0.41			View	N/A
5/9/2011		$0.41	$0.44			View	N/A
3/31/2011		$0.32	$0.23			View	N/A
11/4/2010	Q3 2010	$0.39	$0.39			View	N/A
8/5/2010	Q2 2010	$0.34	$0.38			View	N/A
5/5/2010	Q1 2010	$0.27	$0.33			View	N/A
3/4/2010	Q4 2009	$0.19	$0.21			View	N/A
10/29/2009	Q3 2009	$0.19	$0.23			View	N/A
7/30/2009	Q2 2009	$0.18	$0.20			View	N/A
4/29/2009	Q1 2009	$0.12	$0.17			View	N/A
3/12/2009	Q4 2008		$0.07			View	N/A
11/6/2008	Q3 2008	$0.11	$0.11			View	N/A
8/7/2008	Q2 2008	$0.09	$0.11			View	N/A
5/12/2008	Q1 2008	$0.11	$0.10			View	N/A
3/12/2008	Q4 2007	$0.06	$0.04			View	N/A

(Earnings results data provided by Zacks Investment Research)

Medifast (NYSE:MED) Dividend Information

Medifast pays an annual dividend of $1.92 per share, with a dividend yield of 1.92%. MED's next quarterly dividend payment will be made on Tuesday, May 8. Medifast pays out 83.84% of its earnings out as a dividend.

Next Dividend:	5/8/2018
Annual Dividend:	$1.92
Dividend Yield:	1.92%
Dividend Growth:	0.00% (3 Year Average)
Payout Ratio:	83.84% (Trailing 12 Months of Earnings) 59.08% (Based on This Year's Estimates) 48.00% (Based on Next Year's Estimates)
Frequency:	Quarterly Dividend

Dividend Payments by Quarter for Medifast (NYSE:MED)

Medifast (NYSE:MED) Dividend History by Quarter

Announced	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
3/16/2018	quarterly	$0.48	2.14%	3/28/2018	3/30/2018	5/8/2018
12/7/2017	quarterly	$0.48	2.69%	12/21/2017	12/22/2017	2/8/2018
9/7/2017	quarterly	$0.32	2.31%	9/21/2017	9/22/2017	11/9/2017
6/7/2017	Quarterly	$0.32	3.1%	6/21/2017	6/23/2017	8/9/2017
3/8/2017	quarterly	$0.32	2.92%	3/21/2017	3/23/2017	5/9/2017
12/9/2016	quarterly	$0.32	3.13%	12/21/2016	12/23/2016	2/9/2017
9/9/2016	quarterly	$0.25	2.75%	9/21/2016	9/23/2016	11/10/2016
6/16/2016	quarterly	$0.25	3.04%	6/23/2016	6/27/2016	8/10/2016
3/10/2016	quarterly	$0.25	3.25%	3/17/2016	3/21/2016	5/10/2016
12/16/2015	special	$0.25		12/23/2015	12/28/2015	2/10/2016

(Data available from 1/1/2013 forward)

Medifast (NYSE MED) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 5.40%
Institutional Ownership Percentage: 87.89%

Insider Trading History for Medifast (NYSE:MED)

Medifast (NYSE MED) Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
3/20/2018	Charles P Connolly	Director	Sell	8,000	$90.95	$727,600.00	45,342
3/15/2018	Charles P Connolly	Director	Sell	7,500	$89.31	$669,825.00	40,342
3/8/2018	Michael C Macdonald	Director	Sell	20,000	$84.45	$1,689,000.00	334,188
12/1/2017	Glenn W Welling	Director	Sell	275,000	$64.60	$17,765,000.00
11/13/2017	Glenn W Welling	Director	Sell	250,000	$65.00	$16,250,000.00
9/21/2017	Ralph Rushton	Director	Sell	25,000	$0.18	$4,500.00
9/6/2017	Jeremy John Martin	Director	Sell	131,500	$0.18	$23,670.00
7/7/2017	Simon T.P. Ridgway	Insider	Buy	1,500	$0.15	$225.00
7/5/2017	Simon T.P. Ridgway	Insider	Buy	29,000	$0.15	$4,350.00
3/14/2017	Glenn W Welling	Director	Buy	17,084	$41.33	$706,081.72	5,309
11/15/2016	Glenn W Welling	Director	Buy	35,000	$39.02	$1,365,700.00	2,670
11/9/2016	Jeffrey J Brown	Director	Buy	10,000	$38.71	$387,100.00	13,254
5/31/2016	Balanced Master Fund L Visium	Major Shareholder	Sell	1,350,000	$30.25	$40,837,500.00	1,247,882
4/1/2016	Margaret Sheetz	COO	Sell	8,333	$30.02	$250,156.66	327,346
2/1/2016	Margaret Sheetz	COO	Sell	8,333	$28.62	$238,490.46	336,762
12/1/2015	Margaret Sheetz	COO	Sell	8,333	$29.92	$249,323.36	353,428
11/2/2015	Margaret Sheetz	COO	Sell	8,333	$28.72	$239,323.76	361,761
10/5/2015	Margaret Sheetz	COO	Sell	8,333	$28.88	$240,657.04	370,094
9/4/2015	Simon T.P. Ridgway	Director	Buy	4,000	$0.08	$320.00
9/3/2015	Margaret Sheetz	COO	Sell	6,864	$28.00	$192,192.00	378,427
9/2/2015	Margaret Sheetz	COO	Sell	1,469	$28.00	$41,132.00	385,291
9/1/2015	Simon T.P. Ridgway	Director	Buy	16,000	$0.08	$1,280.00
8/25/2015	Simon T.P. Ridgway	Director	Buy	1,000	$0.0850	$85.00
8/24/2015	Simon T.P. Ridgway	Director	Buy	2,000	$0.09	$180.00
8/19/2015	Simon T.P. Ridgway	Director	Buy	15,000	$0.0950	$1,425.00
8/18/2015	Simon T.P. Ridgway	Director	Buy	35,000	$0.0950	$3,325.00
8/17/2015	Radius Gold Inc.	Insider	Buy	5,000	$0.09	$450.00
8/14/2015	Radius Gold Inc.	Insider	Buy	35,000	$0.10	$3,500.00
8/14/2015	Simon T.P. Ridgway	Director	Buy	10,000	$0.0950	$950.00
6/25/2015	Moduslink Global Solutions Inc	Major Shareholder	Sell	29,654	$33.03	$979,471.62
6/23/2015	Moduslink Global Solutions Inc	Major Shareholder	Sell	27,443	$33.01	$905,893.43
6/22/2015	Moduslink Global Solutions Inc	Major Shareholder	Sell	9,494	$33.01	$313,396.94
6/11/2015	Barry B Bondroff	Director	Sell	1,666	$31.88	$53,112.08
6/10/2015	Margaret Sheetz	COO	Sell	8,337	$32.00	$266,784.00
6/4/2015	John P Mcdaniel	Director	Sell	3,000	$32.14	$96,420.00
8/18/2014	Jeannette M Mills	EVP	Sell	3,000	$28.03	$84,090.00
6/10/2014	Jason L Groves	EVP	Sell	3,250	$31.75	$103,187.50
6/10/2014	John P Mcdaniel	Director	Sell	3,500	$31.74	$111,090.00
6/9/2014	Jeannette M Mills	EVP	Sell	2,784	$32.09	$89,338.56
6/5/2014	Charles P Connolly	Director	Sell	7,500	$30.91	$231,825.00
12/2/2013	Margaret Macdonald Sheetz	COO	Sell	18,000	$25.63	$461,340.00	351,292
11/22/2013	Margaret Macdonald Sheetz	COO	Sell	35,000	$24.33	$851,550.00	369,292

(Data available from 1/1/2013 forward)

Medifast (NYSE MED) News Headlines

Source:

Date	Headline
	Gatheredtable software licensed by Medifast finance.yahoo.com - April 23 at 4:22 PM
	Medifast, Inc. to Announce Financial Results for the First Quarter Ended March 31, 2018 finance.yahoo.com - April 20 at 9:45 AM
	Sidoti Reaffirms "Neutral" Rating for Medifast (MED) www.americanbankingnews.com - April 19 at 2:24 PM
	How Does Medifast Inc’s (NYSE:MED) Earnings Growth Stack Up Against Industry Performance? finance.yahoo.com - April 18 at 9:34 AM
	Market Volatility is Not a Worry With These 5 Low-Beta Stocks finance.yahoo.com - April 13 at 9:59 AM
	Analyzing Greencore Group (GNCGY) and Medifast (MED) www.americanbankingnews.com - April 7 at 10:10 AM
	Financial Review: McCormick & Company, Incorporated (MKC) & Medifast (MED) www.americanbankingnews.com - April 4 at 9:34 PM
	Bull of the Day: Medifast Inc. (MED) finance.yahoo.com - April 4 at 5:08 PM
	Medifast, Signet Jewelers and NVIDIA highlighted as Zacks Bull and Bear of the Day finance.yahoo.com - April 4 at 5:08 PM
	Earnings Estimates Moving Higher for Medifast (MED): Time to Buy? finance.yahoo.com - April 4 at 5:08 PM
	Medifast (MED) Lifted to Strong-Buy at ValuEngine www.americanbankingnews.com - April 3 at 12:10 PM
	Critical Analysis: Medifast (MED) & Greencore Group (GNCGY) www.americanbankingnews.com - April 2 at 7:16 PM
	Zacks Investment Research Upgrades Medifast (MED) to "Buy" www.americanbankingnews.com - March 31 at 4:56 PM
	Medifast (MED) Lowered to "Hold" at Zacks Investment Research www.americanbankingnews.com - March 30 at 10:02 PM
	Zacks Investment Research Lowers Medifast (MED) to Hold www.americanbankingnews.com - March 29 at 11:27 AM
	Under Armour, Medifast among Greater Baltimore stocks up through first quarter www.bizjournals.com - March 26 at 4:16 PM
	Financial Analysis: Greencore Group (GNCGY) & Medifast (MED) www.americanbankingnews.com - March 26 at 7:34 AM
	Conagra (CAG) Beats on Q3 Earnings, Raises FY18 EPS View finance.yahoo.com - March 23 at 4:19 PM
	Can The Uptrend Continue for Medifast (MED)? finance.yahoo.com - March 23 at 4:19 PM
	Medifast Inc (MED) Director Charles P. Connolly Sells 8,000 Shares www.americanbankingnews.com - March 22 at 7:14 PM
	Zacks.com featured highlights include: Medifast, LCI, Vectrus, Duluth and Patrick finance.yahoo.com - March 21 at 4:20 PM
	Medifast Inc (MED) Director Charles P. Connolly Sells 7,500 Shares www.americanbankingnews.com - March 19 at 7:28 PM
	Medifast Inc (MED) Announces $0.48 Quarterly Dividend www.americanbankingnews.com - March 16 at 5:54 PM
	Medifast, Inc. Announces Quarterly Dividend finance.yahoo.com - March 15 at 4:51 PM
	Medifast Inc (MED) Director Sells $1,689,000.00 in Stock www.americanbankingnews.com - March 13 at 10:11 PM
	5 Stocks With Recent Price Strength to Maximize Your Returns finance.yahoo.com - March 13 at 6:15 PM
	Medifast (MED) Upgraded to "Strong-Buy" at Zacks Investment Research www.americanbankingnews.com - March 10 at 6:06 AM
	Q1 2018 Earnings Forecast for Medifast Inc (MED) Issued By DA Davidson www.americanbankingnews.com - March 9 at 7:54 AM
	Medifast (MED) Price Target Raised to $108.00 at DA Davidson www.americanbankingnews.com - March 8 at 11:04 PM
	Today’s Research Reports on Stocks to Watch: Weight Watchers International and Medifast finance.yahoo.com - March 8 at 9:55 AM
	Q3 2018 EPS Estimates for Medifast Inc (MED) Increased by Analyst www.americanbankingnews.com - March 8 at 8:08 AM
	Up 35%, this Baltimore company's stock is one of the biggest gainers in the U.S. today finance.yahoo.com - March 7 at 5:11 PM
	Why Autodesk, H&R Block, and Medifast Jumped Today finance.yahoo.com - March 7 at 5:11 PM
	Medifast (MED) Upgraded by Sidoti to "Buy" www.americanbankingnews.com - March 7 at 11:58 AM
	Medifast profit up 78% in 4Q; activist investor steps down from board finance.yahoo.com - March 7 at 9:41 AM
	Medifast (MED) Announces Quarterly Earnings Results, Beats Expectations By $0.12 EPS www.americanbankingnews.com - March 6 at 7:17 PM
	Medifast (MED) Updates FY18 Earnings Guidance www.americanbankingnews.com - March 6 at 5:12 PM
	Medifast (MED) Releases Q1 Earnings Guidance www.americanbankingnews.com - March 6 at 5:12 PM
	Medifast, Inc. Announces Fourth Quarter and Full Year 2017 Financial Results finance.yahoo.com - March 6 at 4:44 PM
	WINTON GROUP Ltd Takes Position in Medifast Inc (MED) www.americanbankingnews.com - March 6 at 3:31 PM
	Should You Buy Medifast Inc (NYSE:MED) For Its Dividend? finance.yahoo.com - March 6 at 9:25 AM
	Medifast's entry into Asia is first step in aggressive international expansion www.bizjournals.com - March 4 at 5:15 PM
	Medifast (MED) Upgraded to Buy at ValuEngine www.americanbankingnews.com - March 4 at 3:01 PM
	Medifast Inc (MED) Shares Bought by Bogle Investment Management L P DE www.americanbankingnews.com - March 4 at 4:57 AM
	Medifast to begin selling in Hong Kong and Singapore next year finance.yahoo.com - March 1 at 4:45 PM
	Martingale Asset Management L P Reduces Stake in Medifast Inc (MED) www.americanbankingnews.com - March 1 at 9:34 AM
	Medifast Announces Global Expansion with its Lifestyle Brand, OPTAVIA® finance.yahoo.com - February 28 at 9:29 AM
	EAM Investors LLC Acquires 25,831 Shares of Medifast Inc (MED) www.americanbankingnews.com - February 27 at 3:00 PM
	Systematic Financial Management LP Decreases Position in Medifast Inc (MED) www.americanbankingnews.com - February 27 at 11:28 AM
	Arrowstreet Capital Limited Partnership Has $13.24 Million Holdings in Medifast Inc (MED) www.americanbankingnews.com - February 27 at 4:34 AM

Medifast (NYSE:MED) SEC Filings

Form Type:

Ownership Filings:

This page is loading this company's SEC Filings. Please wait...

Medifast (NYSE:MED) Income Statement, Balance Sheet and Cash Flow Statement

Medifast (NYSE MED) Stock Chart for Wednesday, April, 25, 2018

Loading chart…

This page was last updated on 4/25/2018 by MarketBeat.com Staff